A Clinical-EEG Study of Sleepiness and Psychological Symptoms in Pharmacoresistant Epilepsy Patients Treated with Lacosamide

Table 2

Interictal EEG abnormalities and seizures frequency after LCM.

Patient	IIAs/10 min; 𝑡0	IIAs/10 min; 𝑡1	% variation IIAs in (𝑡1−𝑡0)	Seizures/month; 𝑡0	Seizures/month; 𝑡1	% variation seizure in frequency; (𝑡1−𝑡0)
No. 1	22,22	25,77	+14	15,16	7,66	−50
No. 2	2,44	1,55	−37	4,66	0	−100
No. 3	1,44	0,77	−45	4	3,16	−21
No. 4	0,33	0,22	−34	22,16	9,16	−59
No. 5	0,88	1	+12	10,16	7,16	−30
No. 6	0,44	0,44	0	3,83	4,33	+12
No. 7	0,77	0,55	−29	4,33	4,33	0
No. 8	0,66	0,44	−34	9,83	7	−29
No. 9	6,66	6,44	−4	54,16	24,16	−56
No. 10	1,88	1,22	−36	3,66	3,66	0
Pooled	3,77 ± 2,13	3,84 ± 2,50	−19,3	13,19 ± 4,94	7,06 ± 2,07	−33,3

Values in bottom row concerning columns 2, 3, 4, and 6 are expressed as mean ± S.E.M.
IIAS: interictal EEG abnormalities.